We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$836M
AUM Growth
+$24.5M
Cap. Flow
-$7.75M
Cap. Flow %
-0.93%
Top 10 Hldgs %
36.28%
Holding
188
New
7
Increased
26
Reduced
40
Closed
4

Top Buys

Rank Stock Value
1
VVX icon
V2X
VVX
+$2.62M
2
DVA icon
DaVita
DVA
+$1.37M
3
XLNX
Xilinx Inc
XLNX
+$1.35M
4
NBR icon
Nabors Industries
NBR
+$1M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$945K

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$3.14M
2
BHI
Baker Hughes
BHI
+$2.79M
3
CB icon
Chubb
CB
+$1.3M
4
A icon
Agilent Technologies
A
+$1.24M
5
NOC icon
Northrop Grumman
NOC
+$1.19M

Sector Composition

Rank Sector Weight
1 Technology 35.87%
2 Financials 23.01%
3 Healthcare 17.35%
4 Communication Services 6.79%
5 Energy 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VC icon
76
Visteon
VC
$2.77B
$2.5M 0.3%
23,405
– –
EPC icon
77
Edgewell Personal Care
EPC
$1.27B
$2.5M 0.3%
26,238
– –
WOOF
78
DELISTED
VCA Inc.
WOOF
$2.46M 0.29%
50,500
– –
IPG
79
DELISTED
Interpublic Group of Companies
IPG
$2.35M 0.28%
113,100
– –
COV
80
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$2.34M 0.28%
22,900
– –
GSBC icon
81
Great Southern Bancorp
GSBC
$863M
$2.33M 0.28%
58,720
– –
JNJ icon
82
Johnson & Johnson
JNJ
$635B
$2.27M 0.27%
21,700
– –
ACH
83
Accendra Health
ACH
$240M
$2.27M 0.27%
64,600
– –
UIS icon
84
Unisys
UIS
$227M
$2.26M 0.27%
76,700
-7,700
-9% -$194K
CRUS icon
85
Cirrus Logic
CRUS
$6.74B
$2.19M 0.26%
93,050
– –
NVS icon
86
Novartis
NVS
$295B
$2.19M 0.26%
26,338
– –
LLY icon
87
Eli Lilly
LLY
$1.07T
$2.13M 0.26%
30,900
-500
-2% -$33.8K
BHI
88
DELISTED
Baker Hughes
BHI
$2M 0.24%
35,660
-49,556
-58% -$2.79M
ZBH icon
89
Zimmer Biomet
ZBH
$17.7B
$1.89M 0.23%
17,201
– –
CI icon
90
Cigna
CI
$76.6B
$1.87M 0.22%
18,200
– –
PDCO
91
DELISTED
Patterson Companies, Inc.
PDCO
$1.85M 0.22%
38,400
– –
AVG
92
DELISTED
AVG Technologies N.V.
AVG
$1.81M 0.22%
91,700
– –
CRL icon
93
Charles River Laboratories
CRL
$10.9B
$1.78M 0.21%
27,900
+1,600
+6% +$100K
ILMN icon
94
Illumina
ILMN
$29.4B
$1.72M 0.21%
9,602
– –
AMBA icon
95
Ambarella
AMBA
$2.99B
$1.72M 0.21%
33,925
-8,150
-19% -$381K
GSK icon
96
GSK
GSK
$103B
$1.62M 0.19%
30,240
– –
OCR
97
DELISTED
OMNICARE INC
OCR
$1.6M 0.19%
21,900
– –
MCK icon
98
McKesson
MCK
$98.5B
$1.57M 0.19%
7,550
-3,700
-33% -$752K
UNH icon
99
UnitedHealth
UNH
$382B
$1.57M 0.19%
15,500
– –
AIZ icon
100
Assurant
AIZ
$13.7B
$1.55M 0.19%
22,670
– –
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Oak Associates held 188 positions worth $836M, up 3% from $811M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Oak Associates's Q4 2014 filing shows 7 new, 26 increased, 40 reduced and 4 closed positions. Its largest new stake was V2X: 103,055 shares worth $2.82M. The largest sale was Lockheed Martin, an estimated $3.14M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Financials and Healthcare.

  • Oak Associates's largest Q4 2014 buy was V2X: 103,055 shares worth $2.82M.
  • Oak Associates added most to Xilinx Inc in Q4 2014, an estimated $1.35M increase.
  • Oak Associates's biggest Q4 2014 reduction was Baker Hughes, cutting an estimated $2.79M.
  • Oak Associates fully exited Lockheed Martin in Q4 2014, selling an estimated $3.14M.
  • Oak Associates's ten largest holdings make up 36% of its $836M portfolio in Q4 2014.
  • Oak Associates opened 7 new positions and closed 4 in Q4 2014.
  • Oak Associates's portfolio value rose 3% quarter-over-quarter to $836M.

Based on Oak Associates's 13F filing for Q4 2014, filed 9 Feb 2015.